According to a new report from Intel Market Research, the global Biological Agent Detection (PCR, Immunoassay) Device market was valued at USD 4.4 billion in 2025 and is projected to reach USD 9.9 billion by 2034, growing at a robust CAGR of 9.7% during the forecast period (2026–2034). This growth is propelled by rising global investments in biodefense programs, heightened concern over...

According to Research Intelo's latest market intelligence study, the Portable PCR Devices Market is experiencing a significant upswing in demand, driven by rapid technological innovations, the need for real-time diagnostics, and an increasingly mobile healthcare infrastructure. These compact molecular diagnostic tools are redefining point-of-care testing, particularly in remote and...